Skip to main content

Featured

How Canada's 2026 Tax Changes Put More Money Back in Your Pocket

  Big news for your paycheque Canada's 2026 tax changes are officially in effect — and for most Canadians, they mean less tax, more savings room, and a bigger take-home. Here's everything you need to know in plain language. Lower rates, bigger RRSP room, and smart moves that could save you up to $840 this year 💡 Tax Tips 🇨🇦 Canada 📅 May 2026 If you haven't checked your pay stub lately, now is a great time. Canada's federal government rolled out several meaningful tax changes for 2026 — and whether you're a first-time filer, a savvy RRSP investor, or just trying to keep more of what you earn, these updates affect you. We've broken it all down below so you know exactly where the savings are and how to take full advantage. 14% New lowest federal tax rate (down from 15%) $840 Max savings for a two-income couple $33,810 2026 RRSP contribution limit $7,000 Annual TFSA contribution room 1. Your Tax Rate Just Got Lower The biggest headline: the lowest federal income...

article

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Comments